Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
PUT
PPG Industries
PPG
$26.2B
| $8.08M | ﹤0.01% |
56,000
-127,900
| -70% | -$17.8M |
|
2802
PUT
Revolve Group
RVLV
$1.89B
| $8.08M | ﹤0.01% |
259,100
+175,100
| +208% | +$3.9M |
|
|
SAGE
2803
CALL
DELISTED
Sage Therapeutics
SAGE
| $8.07M | ﹤0.01% |
93,300
-39,900
| -30% | -$2.94M |
|
|
LOKB.U
2804
DELISTED
Live Oak Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-th
LOKB.U
| $8.06M | ﹤0.01% |
+743,231
| New | +$7.78M |
|
2805
Emergent Biosolutions
EBS
$391M
| $8.06M | ﹤0.01% |
89,975
+45,734
| +103% | +$4.2M |
|
2806
PUT
Transocean
RIG
$5.78B
| $8.06M | ﹤0.01% |
3,489,000
+86,600
| +3% | +$127K |
|
2807
Pegasystems
PEGA
$5.22B
| $8.06M | ﹤0.01% |
120,930
+68,414
| +130% | +$4.36M |
|
2808
Commault Systems
CVLT
$5.47B
| $8.05M | ﹤0.01% |
145,385
+102,480
| +239% | +$4.79M |
|
|
PDCO
2809
DELISTED
Patterson Companies, Inc.
PDCO
| $8.04M | ﹤0.01% |
271,493
+242,254
| +829% | +$6.86M |
|
2810
CALL
Protolabs
PRLB
$2.11B
| $8.04M | ﹤0.01% |
52,400
+3,200
| +7% | +$451K |
|
2811
TTM Technologies
TTMI
$13.8B
| $8.02M | ﹤0.01% |
581,076
+222,321
| +62% | +$2.84M |
|
|
GTM
2812
PUT
ZoomInfo Technologies
GTM
$1.07B
| $8.01M | ﹤0.01% |
166,100
-27,400
| -14% | -$1.18M |
|
|
BZUN
2813
CALL
Baozun
BZUN
$176M
| $8.01M | ﹤0.01% |
233,100
+2,700
| +1% | +$99K |
|
|
KDNY
2814
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $8.01M | ﹤0.01% |
504,798
+501,844
| +16,989% | +$7.57M |
|
2815
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $8M | ﹤0.01% |
19,056
-4,727
| -20% | -$1.82M |
|
2816
CALL
BILL Holdings
BILL
$4.84B
| $8M | ﹤0.01% |
58,600
+33,200
| +131% | +$3.92M |
|
2817
Chemours
CC
$2.7B
| $8M | ﹤0.01% |
322,680
-1,261,661
| -80% | -$30M |
|
2818
CALL
iShares Russell 2000 Growth ETF
IWO
$15B
| $8M | ﹤0.01% |
27,900
-10,200
| -27% | -$2.6M |
|
2819
CALL
Baker Hughes
BKR
$61.3B
| $7.99M | ﹤0.01% |
383,400
+107,200
| +39% | +$1.88M |
|
2820
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.3B
| $7.99M | ﹤0.01% |
237,868
-213
| -0.1% | -$6.88K |
|
2821
PUT
Omnicom Group
OMC
$22.4B
| $7.99M | ﹤0.01% |
128,100
-3,800
| -3% | -$217K |
|
2822
Barclays
BCS
$94.5B
| $7.99M | ﹤0.01% |
999,318
+944,910
| +1,737% | +$6.32M |
|
2823
PUT
Equifax
EFX
$20.8B
| $7.98M | ﹤0.01% |
41,400
-22,400
| -35% | -$3.77M |
|
2824
XP
XP
$8.77B
| $7.98M | ﹤0.01% |
201,219
-14,988
| -7% | -$612K |
|
2825
CALL
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.05B
| $7.97M | ﹤0.01% |
+104,500
| New | +$6.91M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.